SITC TOXICITY MANAGEMENT WORKSHOP
March 31, 2017 • Washington, DC
SITC invites you to attend the consensus-building Toxicity Management Workshop from 8 a.m. – 6 p.m. to address two pressing needs for the advancement of the field:
Creating treatment algorithms for managing immunotherapy-related toxicities
Developing standardized templates for adverse event management in protocols for clinical trials
The workshop will be a multi-stakeholder effort of 100 thought leaders from government, academia, industry, scientific organizations and other related entities. These stakeholders want to move quickly and convene to address the growing need for standardization to provide better treatments and ultimately, improve patient outcomes. Register today, as space is limited. Onsite registration is available, provided there is space.
The Toxicity Management Workshop is supported in part by grants from AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb and Merck & Co., Inc.
SITC 2017 – MARK YOUR CALENDARS!
November 8-12, 2017 • National Harbor, MD
Call for Abstracts – Submit Now Through August 1, 2017
SITC is now accepting regular abstracts and late-breaking abstract applications from members and nonmembers for the upcoming 32nd Annual Meeting. Introduce your research at SITC 2017 and present alongside luminaries in the cancer immunotherapy field. This year’s abstract submission period will close on August 1. Learn more and submit your abstract.
Did you know? SITC early career members who submit an abstract to SITC 2017 as both primary and presenting author are eligible for one of 32 SITC Young Investigator Awards.
Advance Registration & Housing – Open for SITC Members
New this year, SITC 2017 registration is required prior to reserving a room in the SITC hotel block. Advance registration is open to SITC members now! If you have not already done so, join SITC or renew your membership to take advantage of early registration and hotel accommodations. Register for SITC’s 32nd Annual Meeting & Pre-Conference Programs. Registration and housing will open to the general public April 7, 2017.
UPCOMING SITC EVENTS
American Association for Cancer Research Cancer Immunology Working Group Town Hall and Reception
Presented by the American Association for Cancer Research (AACR) Cancer Immunology (CIMM) Working Group in collaboration with the Society for Immunotherapy of Cancer
April 2, 2017 • Washington, DC
Held during the AACR Annual Meeting, this session will highlight recent research in immunology and immunotherapy. Program speakers include SITC President Lisa H. Butterfield, PhD and SITC member Marcus W. Bosenberg, MD, PhD. Learn more and register.
Immunotherapy Session at the 17th Pan Arab Cancer Congress
Presented by the Arab Medical Association Against Cancer and the Algerian Society of Medical Oncology in collaboration with the Society for Immunotherapy of Cancer
April 21, 2017 • Algiers, Algeria
New this year, SITC is organizing an immunotherapy session in Algeria to provide oncology practitioners with an understanding of the mechanisms of action and current/emerging clinical applications of immunotherapy treatment methods. This session, held during the 17th Pan Arab Cancer Congress, will explore cancer management practices in 22 Arabic countries. Learn more and register.
Advances in Cancer Immunotherapy™ (ACI) – San Francisco, CA
Presented by the Society for Immunotherapy of Cancer in collaboration with the American Academy of Emergency Physicians and the Association of Community Cancer Centers
May 6, 2017 • San Francisco, CA
Register now for this introductory CME-, CNE- and CPE-certified series or share with your colleagues! The program provides oncologists, nurses, pharmacists, emergency physicians, and the entire cancer care team a greater understanding of the mechanisms and clinical application of cancer immunotherapies, the management of adverse events and strategies to overcome operational and financial barriers to implementing immunotherapy. SITC members receive discounted registration rates. Learn more and register.
The International Symposium on Immunotherapy
Presented by the Institute for Cancer Vaccines and Immunotherapy in collaboration with the Society for Immunotherapy of Cancer
May 12-13, 2017 • London, England
The Institute for Cancer Vaccines and Immunotherapy – previously known as the Cancer Vaccine Institute – is hosting this symposium for researchers, academics and clinicians in immunotherapy, immunology and/or oncology. Leading immunotherapy experts will share their latest scientific findings on the opportunities and challenges that exist today in immunotherapy with an emphasis on combinations of chemotherapy and immunotherapy and various immunotherapy agents. Learn more and register.
Cancer Immunity & Immunotherapy
Presented by the Federation of Clinical Immunology Societies (FOCIS) and the Society for Immunotherapy of Cancer
June 14, 2017 • Chicago, IL
This course, held during the FOCIS Annual Meeting, will review tumor immunology as the foundation for the current practice of cancer immunotherapy emphasizing fundamental principles, recent clinical advances, current limitations, and opportunities for furthering clinical progress. Attendees may take this course in combination with FOCIS 2017 or attend the course only. SITC members receive discounted registration rates. Learn more and register.
Incorporating Radiation Oncology Into Immunotherapy
Presented by the American Society for Radiation Oncology (ASTRO) in collaboration with the Society for Immunotherapy of Cancer
June 15-16, 2017 • Bethesda, MD
With the current surge in cancer immunotherapy use and the potential for identifying novel solutions to overcome immune suppressive barriers, the focus on how to best combine radiotherapy and cancer immunotherapy has never been more timely and important. This workshop will cover many of the questions surrounding promising new approaches including the best combination, sequencing, dosages, timing of radiation and the use of valuable biomarkers in immunotherapy. SITC members receive discounted registration rates. Learn more and register.
Email email@example.com for more information on discounted registration rates.
Did you know? SITC members receive up to a 25% savings on registration rates to SITC’s Advances in Cancer Immunotherapy™ (ACI) CME-, CNE- and CE-certified live education programs. Join SITC, renew your membership, or check your current membership status.
JUST RELEASED: NEW SITC-MEDSCAPE ACTIVITY
Developed through a partnership with Medscape Oncology, SITC is pleased to offer a new CME- and CE-certified activity through the Clinical Advances in Cancer Immunotherapy portal titled Patient-Centered Care in Head and Neck Squamous Cell Carcinoma (HNSCC). Experience this recently released activity.
Did you know? You do not have to be a member to access and share SITC’s easy to understand Patient Cancer Resource Guide: Understanding Cancer Immunotherapy with patients and patient advocates. Read or download the latest edition for free.